Perhaps the biggest trend health information technology today is the movement away from traditional picture archiving and communications systems (PACS) and cardiovascular information systems (CVIS) to enterprise imaging and data management systems. This migration is important, because it will fundamentally change how clinicians have been accessing images and patient information for the past 20 years.
Millions of people take angiotensin receptor blockers (ARBs) to help treat heart failure. But it turns out not all ARBs are created equally, according to one Nova Southeastern University (NSU) researcher’s findings.
The U.S. Food and Drug Administration announced that it will strengthen its review of automated external defibrillators (AEDs) to help improve the quality and reliability of these devices.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Ostar Healthcare Technology, a Washington State Based TeleHealth Solutions company, announced the North American launch of Cellular TeleHealth Blood Pressure Monitoring System.
The Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology (ONC) released Connecting Health and Care for the Nation: A Shared Nationwide Interoperability Roadmap Version 1.0.
Coronary bypass graft surgery commonly used to treat patients with coronary heart disease results in improved quality of life but also costs more than another often-used less invasive technique, Christiana Care Health System researchers reported in January in the Journal of the American College of Cardiology.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
A researcher in the University of the Basque Country’s (UPV/EHU) Department of Communications Engineering has developed the Ladon security protocol, an efficient mechanism to authenticate, authorize and establish the end-to-end keys (keys for communication between the terminal used by the doctor and the patient's device) for ICDs.
Researchers at Okayama University and Okayama University Hospital show that children suffering from a condition known as hypoplastic left heart syndrome experienced some improvement in cardiac function in the months following injection of cardiosphere-derived cells (CDCs).
Healthcare Supply Chain Association (HSCA) President Curtis Rooney released a statement on the annual Budget and Economic Outlook compiled by the Congressional Budget Office (CBO).
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
AliveCor Inc. announced it has received CE Mark clearance for its automated analysis process (algorithm) to detect atrial fibrillation (AF). The latest version of the AliveECG app for users in the United Kingdom and Ireland now provides patients with real-time AF detection in electrocardiogram (ECG) recordings using the AliveCor Heart Monitor.
The British Medical Journal published results online that show Abbott’s Architect Stat High Sensitive Troponin-I (hsTnl) test may help doctors to detect twice as many myocardial infarctions (MI) in women. Results showed that Abbott’s test was able to diagnose MI in 22 percent of cases for women compared to a standard of 11 percent, when using a sex-specific threshold.
In his lecture, Harrington will argue that simplification of larger trials, better early-phase investigations and the use of electronic health records can ease the path to new research.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Biosensors International Group has announced a distribution agreement with Veryan Medical Ltd. for BioMimics 3D, a nitinol stent with three-dimensional helical geometry designed for use in the superficial femoral artery.
ECRI Institute has created a report that offers an overview of drug-eluting balloon (DEB) technology, “Health Technology Forecast report, "Drug-eluting Angioplasty Balloons for Preventing Restenosis after Revascularization." The report details some of the key questions regarding DEBs.
SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct a clinical study of the effectiveness of the SynCardia temporary Total Artificial Heart for permanent use, also called destination therapy.